These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
516 related articles for article (PubMed ID: 15674328)
1. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer. Iliopoulos D; Guler G; Han SY; Johnston D; Druck T; McCorkell KA; Palazzo J; McCue PA; Baffa R; Huebner K Oncogene; 2005 Feb; 24(9):1625-33. PubMed ID: 15674328 [TBL] [Abstract][Full Text] [Related]
2. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies. Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866 [TBL] [Abstract][Full Text] [Related]
3. Concordant loss of fragile gene expression early in breast cancer development. Guler G; Uner A; Guler N; Han SY; Iliopoulos D; McCue P; Huebner K Pathol Int; 2005 Aug; 55(8):471-8. PubMed ID: 15998374 [TBL] [Abstract][Full Text] [Related]
4. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation. Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840 [TBL] [Abstract][Full Text] [Related]
5. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance. Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757 [TBL] [Abstract][Full Text] [Related]
6. Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas. Foja S; Goldberg M; Schagdarsurengin U; Dammann R; Tannapfel A; Ballhausen WG Liver Int; 2005 Dec; 25(6):1202-8. PubMed ID: 16343073 [TBL] [Abstract][Full Text] [Related]
7. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma. Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837 [TBL] [Abstract][Full Text] [Related]
8. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma. Guler G; Uner A; Guler N; Han SY; Iliopoulos D; Hauck WW; McCue P; Huebner K Cancer; 2004 Apr; 100(8):1605-14. PubMed ID: 15073846 [TBL] [Abstract][Full Text] [Related]
9. Hypermethylation patterns in the Fhit regulatory region are tissue specific. Guler G; Iliopoulos D; Han SY; Fong LY; Lubet RA; Grubbs CJ; Huebner K Mol Carcinog; 2005 Jul; 43(3):175-81. PubMed ID: 15937960 [TBL] [Abstract][Full Text] [Related]
10. Loss expression of active fragile sites genes associated with the severity of breast epithelial abnormalities. Wang TT; Frezza EE; Ma R; Hu SY; Liu CZ; Zhang GY; Wachtel MS; Lü XM; Feng JB; Lü CX Chin Med J (Engl); 2008 Oct; 121(20):1969-74. PubMed ID: 19080258 [TBL] [Abstract][Full Text] [Related]
11. Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer. Yang Q; Nakamura M; Nakamura Y; Yoshimura G; Suzuma T; Umemura T; Shimizu Y; Mori I; Sakurai T; Kakudo K Clin Cancer Res; 2002 Sep; 8(9):2890-3. PubMed ID: 12231533 [TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung. Kim JS; Kim H; Shim YM; Han J; Park J; Kim DH Carcinogenesis; 2004 Nov; 25(11):2165-71. PubMed ID: 15231689 [TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of the fragile histidine triad (FHIT) tumor suppressor gene in vesical tumors of cattle with chronic enzootic hematuria (CEH). Guidi E; Uboldi C; Ferretti L Cytogenet Genome Res; 2008; 120(1-2):173-7. PubMed ID: 18467844 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic silencing contributes to frequent loss of the fragile histidine triad tumour suppressor in basal cell carcinomas. Goldberg M; Rummelt C; Laerm A; Helmbold P; Holbach LM; Ballhausen WG Br J Dermatol; 2006 Dec; 155(6):1154-8. PubMed ID: 17107382 [TBL] [Abstract][Full Text] [Related]
15. 5'CpG island hypermethylation and aberrant transcript splicing both contribute to the inactivation of the FHIT gene in resected non-small cell lung cancer. Tzao C; Tsai HY; Chen JT; Chen CY; Wang YC Eur J Cancer; 2004 Sep; 40(14):2175-83. PubMed ID: 15341994 [TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma. Maruyama R; Sugio K; Yoshino I; Maehara Y; Gazdar AF Cancer; 2004 Apr; 100(7):1472-7. PubMed ID: 15042681 [TBL] [Abstract][Full Text] [Related]
17. 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. Zöchbauer-Müller S; Fong KM; Maitra A; Lam S; Geradts J; Ashfaq R; Virmani AK; Milchgrub S; Gazdar AF; Minna JD Cancer Res; 2001 May; 61(9):3581-5. PubMed ID: 11325823 [TBL] [Abstract][Full Text] [Related]
18. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer. Kim H; Kwon YM; Kim JS; Lee H; Park JH; Shim YM; Han J; Park J; Kim DH J Clin Oncol; 2004 Jun; 22(12):2363-70. PubMed ID: 15197197 [TBL] [Abstract][Full Text] [Related]
19. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Bednarek AK; Laflin KJ; Daniel RL; Liao Q; Hawkins KA; Aldaz CM Cancer Res; 2000 Apr; 60(8):2140-5. PubMed ID: 10786676 [TBL] [Abstract][Full Text] [Related]
20. [Methylation status of FHIT gene in plasma and expression of FHIT gene in cancer tissue of cervical cancer patients]. Ren CC; Miao XH; Yang B; Zhao L; Sun R; Song WQ Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Oct; 23(5):565-7. PubMed ID: 17029211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]